0 Evaluaciones

ID

41371

Descripción

Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. See https://clinicaltrials.gov/ct2/show/NCT00039858 This Form is to be completed on Study Conclusion and is used to verify that no important steps were omitted. Also includes Investigator's Signature.

Link

https://clinicaltrials.gov/ct2/show/NCT00039858

Palabras clave

  1. 14/9/20 14/9/20 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

14 de septiembre de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858

    Study Completion

    1. StudyEvent: ODM
      1. Study Completion
    Administrative Data
    Descripción

    Administrative Data

    Alias
    UMLS CUI-1
    C1320722
    Site #
    Descripción

    Study centre number

    Tipo de datos

    integer

    Alias
    UMLS CUI [1,1]
    C0600091
    UMLS CUI [1,2]
    C0019994
    Patient #
    Descripción

    patient ID

    Tipo de datos

    integer

    Alias
    UMLS CUI [1]
    C2348585
    Visit Date
    Descripción

    visit date

    Tipo de datos

    date

    Alias
    UMLS CUI [1]
    C1320303
    Study Completion
    Descripción

    Study Completion

    Alias
    UMLS CUI-1
    C2348577
    a. Discharge Summary attached?
    Descripción

    Discharge summary

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0743221
    b. Did patient complete study?
    Descripción

    Completion of study by subject

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C2348577
    If b. = YES, complete below (indicate all that apply):
    Descripción

    If b. = YES, complete below (indicate all that apply):

    Alias
    UMLS CUI-1
    C2348577
    Resolution of underlying condition requiring anticoagulation
    Descripción

    Resolution of underlying condition requiring anticoagulation

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1514893
    UMLS CUI [1,2]
    C0277554
    UMLS CUI [1,3]
    C0449867
    UMLS CUI [1,4]
    C1514873
    Patient transferred to oral or subcutaneous anticoagulation therapy
    Descripción

    Oral or subcutaneous anticoagulation therapy

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0003281
    UMLS CUI [1,2]
    C1527415
    UMLS CUI [2,1]
    C0003281
    UMLS CUI [2,2]
    C0443315
    Patient completed 14 days of study drug
    Descripción

    Study drug trial period complete

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0304229
    UMLS CUI [1,2]
    C0205197
    UMLS CUI [1,3]
    C2347804
    If b. = NO, indicate reason(s) below: (indicate all that apply)
    Descripción

    If b. = NO, indicate reason(s) below: (indicate all that apply)

    Alias
    UMLS CUI-1
    C2348577
    UMLS CUI-2
    C1272696
    Major bleed (as defined per protocol)
    Descripción

    Major bleed

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C3160769
    Bleeding unresponsive to usual clinical interventions
    Descripción

    Bleeding unresponsive to treatment

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0019080
    UMLS CUI [1,2]
    C0205269
    Infusion interrupted for more than 24 consecutive hours
    Descripción

    Interruption of infusion procedures

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C1512900
    UMLS CUI [1,2]
    C0574032
    Adverse event (specify)
    Descripción

    Adverse event

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0877248
    Adverse event - specify:
    Descripción

    Adverse event - specify

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0877248
    UMLS CUI [1,2]
    C1521902
    Intercurrent Illness (specify)
    Descripción

    Intercurrent Illness

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0009488
    Intercurrent Illness - specify:
    Descripción

    Intercurrent Illness - specify

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0009488
    UMLS CUI [1,2]
    C1521902
    Protocol violation (specify)
    Descripción

    Protocol violation

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1709750
    Protocol violation - specify:
    Descripción

    Protocol violation - specify

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C1709750
    UMLS CUI [1,2]
    C1521902
    Surgery (specify)
    Descripción

    Surgery

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C0543467
    Surgery - specify:
    Descripción

    Surgery - specify

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C0543467
    UMLS CUI [1,2]
    C1521902
    Clinical efficacy of drug insufficient or lacking
    Descripción

    Lack of drug efficacy | drug efficacy insuficient

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C0235828
    UMLS CUI [1,2]
    C0304229
    UMLS CUI [2,1]
    C0598333
    UMLS CUI [2,2]
    C0231180
    Patient request to withdraw
    Descripción

    Withdrawal by subject

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1]
    C1710677
    Other (specify)
    Descripción

    Other reason why study not completed by subject

    Tipo de datos

    boolean

    Alias
    UMLS CUI [1,1]
    C2348577
    UMLS CUI [1,2]
    C1272696
    UMLS CUI [1,3]
    C3840932
    Other - specify:
    Descripción

    Other reason why study not completed by subject - specify

    Tipo de datos

    text

    Alias
    UMLS CUI [1,1]
    C2348577
    UMLS CUI [1,2]
    C1272696
    UMLS CUI [1,3]
    C3840932
    UMLS CUI [1,4]
    C1521902
    I HAVE READ THESE CASE REPORT FORMS AND CONFIRM THAT THE INFORMATION GIVEN IS ACCURATE AND COMPLETE
    Descripción

    I HAVE READ THESE CASE REPORT FORMS AND CONFIRM THAT THE INFORMATION GIVEN IS ACCURATE AND COMPLETE

    Alias
    UMLS CUI-1
    C2346576
    Signed:
    Descripción

    Principal Investigator

    Tipo de datos

    text

    Alias
    UMLS CUI [1]
    C2346576
    Date
    Descripción

    Date of Investigator Signature

    Tipo de datos

    date

    Alias
    UMLS CUI [1,1]
    C2346576
    UMLS CUI [1,2]
    C0011008

    Similar models

    Study Completion

    1. StudyEvent: ODM
      1. Study Completion
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Administrative Data
    C1320722 (UMLS CUI-1)
    Study centre number
    Item
    Site #
    integer
    C0600091 (UMLS CUI [1,1])
    C0019994 (UMLS CUI [1,2])
    patient ID
    Item
    Patient #
    integer
    C2348585 (UMLS CUI [1])
    visit date
    Item
    Visit Date
    date
    C1320303 (UMLS CUI [1])
    Item Group
    Study Completion
    C2348577 (UMLS CUI-1)
    Discharge summary
    Item
    a. Discharge Summary attached?
    boolean
    C0743221 (UMLS CUI [1])
    Completion of study by subject
    Item
    b. Did patient complete study?
    boolean
    C2348577 (UMLS CUI [1])
    Item Group
    If b. = YES, complete below (indicate all that apply):
    C2348577 (UMLS CUI-1)
    Resolution of underlying condition requiring anticoagulation
    Item
    Resolution of underlying condition requiring anticoagulation
    boolean
    C1514893 (UMLS CUI [1,1])
    C0277554 (UMLS CUI [1,2])
    C0449867 (UMLS CUI [1,3])
    C1514873 (UMLS CUI [1,4])
    Oral or subcutaneous anticoagulation therapy
    Item
    Patient transferred to oral or subcutaneous anticoagulation therapy
    boolean
    C0003281 (UMLS CUI [1,1])
    C1527415 (UMLS CUI [1,2])
    C0003281 (UMLS CUI [2,1])
    C0443315 (UMLS CUI [2,2])
    Study drug trial period complete
    Item
    Patient completed 14 days of study drug
    boolean
    C0304229 (UMLS CUI [1,1])
    C0205197 (UMLS CUI [1,2])
    C2347804 (UMLS CUI [1,3])
    Item Group
    If b. = NO, indicate reason(s) below: (indicate all that apply)
    C2348577 (UMLS CUI-1)
    C1272696 (UMLS CUI-2)
    Major bleed
    Item
    Major bleed (as defined per protocol)
    boolean
    C3160769 (UMLS CUI [1])
    Bleeding unresponsive to treatment
    Item
    Bleeding unresponsive to usual clinical interventions
    boolean
    C0019080 (UMLS CUI [1,1])
    C0205269 (UMLS CUI [1,2])
    Interruption of infusion procedures
    Item
    Infusion interrupted for more than 24 consecutive hours
    boolean
    C1512900 (UMLS CUI [1,1])
    C0574032 (UMLS CUI [1,2])
    Adverse event
    Item
    Adverse event (specify)
    boolean
    C0877248 (UMLS CUI [1])
    Adverse event - specify
    Item
    Adverse event - specify:
    text
    C0877248 (UMLS CUI [1,1])
    C1521902 (UMLS CUI [1,2])
    Intercurrent Illness
    Item
    Intercurrent Illness (specify)
    boolean
    C0009488 (UMLS CUI [1])
    Intercurrent Illness - specify
    Item
    Intercurrent Illness - specify:
    text
    C0009488 (UMLS CUI [1,1])
    C1521902 (UMLS CUI [1,2])
    Protocol violation
    Item
    Protocol violation (specify)
    boolean
    C1709750 (UMLS CUI [1])
    Protocol violation - specify
    Item
    Protocol violation - specify:
    text
    C1709750 (UMLS CUI [1,1])
    C1521902 (UMLS CUI [1,2])
    Surgery
    Item
    Surgery (specify)
    boolean
    C0543467 (UMLS CUI [1])
    Surgery - specify
    Item
    Surgery - specify:
    text
    C0543467 (UMLS CUI [1,1])
    C1521902 (UMLS CUI [1,2])
    Lack of drug efficacy | drug efficacy insuficient
    Item
    Clinical efficacy of drug insufficient or lacking
    boolean
    C0235828 (UMLS CUI [1,1])
    C0304229 (UMLS CUI [1,2])
    C0598333 (UMLS CUI [2,1])
    C0231180 (UMLS CUI [2,2])
    Withdrawal by subject
    Item
    Patient request to withdraw
    boolean
    C1710677 (UMLS CUI [1])
    Other reason why study not completed by subject
    Item
    Other (specify)
    boolean
    C2348577 (UMLS CUI [1,1])
    C1272696 (UMLS CUI [1,2])
    C3840932 (UMLS CUI [1,3])
    Other reason why study not completed by subject - specify
    Item
    Other - specify:
    text
    C2348577 (UMLS CUI [1,1])
    C1272696 (UMLS CUI [1,2])
    C3840932 (UMLS CUI [1,3])
    C1521902 (UMLS CUI [1,4])
    Item Group
    I HAVE READ THESE CASE REPORT FORMS AND CONFIRM THAT THE INFORMATION GIVEN IS ACCURATE AND COMPLETE
    C2346576 (UMLS CUI-1)
    Investigator's Signature
    Item
    Signed:
    text
    C2346576 (UMLS CUI [1])
    Date of Investigator Signature
    Item
    Date
    date
    C2346576 (UMLS CUI [1,1])
    C0011008 (UMLS CUI [1,2])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial